Neuberger Berman Group’s Inovio Pharmaceuticals INO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-16,887
| Closed | -$156K | – | 1782 |
|
2021
Q1 | $156K | Hold |
16,887
| – | – | ﹤0.01% | 1712 |
|
2020
Q4 | $150K | Hold |
16,887
| – | – | ﹤0.01% | 1637 |
|
2020
Q3 | $196K | Sell |
16,887
-16,350
| -49% | -$190K | ﹤0.01% | 1556 |
|
2020
Q2 | $896K | Sell |
33,237
-16,749
| -34% | -$452K | ﹤0.01% | 1161 |
|
2020
Q1 | $372K | Sell |
49,986
-6,400
| -11% | -$47.6K | ﹤0.01% | 1301 |
|
2019
Q4 | $186K | Hold |
56,386
| – | – | ﹤0.01% | 1486 |
|
2019
Q3 | $116K | Buy |
56,386
+50
| +0.1% | +$103 | ﹤0.01% | 1496 |
|
2019
Q2 | $166K | Buy |
56,336
+30,736
| +120% | +$90.6K | ﹤0.01% | 1502 |
|
2019
Q1 | $95K | Hold |
25,600
| – | – | ﹤0.01% | 1483 |
|
2018
Q4 | $102K | Buy |
+25,600
| New | +$102K | ﹤0.01% | 1536 |
|
2018
Q3 | – | Sell |
-34,718
| Closed | -$136K | – | 1649 |
|
2018
Q2 | $136K | Buy |
34,718
+600
| +2% | +$2.35K | ﹤0.01% | 1671 |
|
2018
Q1 | $161K | Hold |
34,118
| – | – | ﹤0.01% | 1628 |
|
2017
Q4 | $141K | Buy |
34,118
+15,950
| +88% | +$65.9K | ﹤0.01% | 1710 |
|
2017
Q3 | $115K | Buy |
+18,168
| New | +$115K | ﹤0.01% | 1563 |
|